Larvol Delta - Use-of-hUCMSC-Product-BXU001-for-the-Treatment-of-COVID19-With-ARDS

BX-U001 - Baylx

http://clinicaltrials.gov/ct2/show/NCT04452097

Aug 10, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next